METHYL 2-((16.ALPHA.)-17-AMINO-16-HYDROXY-3,11-DIOXOPREGNA-1,4-DIEN-20-YLIDENE)HYDRAZINECARBOXYLATE
UNII WS8L3F826F

Substance Identification & Data

This profile provides standardized clinical and technical data for Methyl 2-((16.alpha.)-17-amino-16-hydroxy-3,11-dioxopregna-1,4-dien-20-ylidene)hydrazinecarboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WS8L3F826F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1424921-05-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WS8L3F826F
CAS Registry Number
1424921-05-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
METHYL 2-((16.ALPHA.)-17-AMINO-16-HYDROXY-3,11-DIOXOPREGNA-1,4-DIEN-20-YLIDENE)HYDRAZINECARBOXYLATE
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Methyl 2-((16.alpha.)-17-amino-16-hydroxy-3,11-dioxopregna-1,4-dien-20-ylidene)hydrazinecarboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

METHYL 2-((16.ALPHA.)-17-AMINO-16-HYDROXY-3,11-DIOXOPREGNA-1,4-DIEN-20-YLIDENE)HYDRAZINECARBOXYLATE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record